Advertisement

The American Journal of Digestive Diseases

, Volume 16, Issue 11, pp 386–401 | Cite as

A newer concept of arthritis and the treatment of arthritic pain and deformity by sympathetic block at the sphenopalatien (nasal) ganglion and the use of the iron salt of the adenylic nucleotide

“The dynamics of muscle tonus” PART IV
  • Simon L. Ruskin
Article

Conclusion

1. A new concept of polyarthritis as a “sympathetic dystrophy” is presented.

2. The prevailing dystrophy could be designated either as arthro-dystrophy or musculo-dystrophy.

3. The correct rationale for treatment becomes clear and points to correction of sympathetic nervous system disturbances and energy inadequacies in muscle metabolism.

4. These disturbances are amenable to treatment through the sympathetic nervous system at the nasal ganglion, the use of the iron salt of the adenylic nucleotide (Ironyl), iron ascorbate, and the coenzymes of the B-complex and amino acids (Co-amino).

5. The disturbances hitherto considered as incurable such as arthritis deformans, Marie-Strumpell’s Disease, and advanced polyarthritis, have been sucessfully treated by this new therapy following the new concept. More recently longstanding poliomyelitis disabilities have also shown dramatic improvement under this type of treatment.

Keywords

Peptic Ulcer Sympathetic Nervous System Sore Throat Nerve Impulse Muscle Spasm 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliography

  1. Beutner, J.; Pharmacol, 31, 305 (1927).Google Scholar
  2. Beutner & Barnes; Science, 95, 212 (1942).CrossRefGoogle Scholar
  3. Beutner, Z.; Physik Chem, 139, 107 (1928).Google Scholar
  4. Brown, George B.; Roll, Paul M.; and Plentl, A. A.; “Studies in Metabolism of Adenine,” Federation Proceedings: Sloan Kettering Insitute for Cancer Research, pp. 517–522 (1947).Google Scholar
  5. Friend, Dale G.; “Iron Ascorbate in the Treatment of Anemia,” New England Journal of Medicine, Vol. 219, No. 23 (Dec. 8, 1938).Google Scholar
  6. Fleisshhacker, H.; “Zur Peroralen and Intravenosen Therapie mit Ascorbinsaurein Eisen,” Wiener, Klin, Wochscher, 776, No. 29 (1938).Google Scholar
  7. Glanzman, E.; “Zur Behandlvng der Kinderanemien Mit Ascorbinsaurein Eisen,” Schweiz, Med. Wochschr, No. 20, 436 (1937).Google Scholar
  8. Gasser, H. S.; “Control of Excitation in the Nervous System,” Bull. N. Y. Academy of Medicine, 13, 324–328.Google Scholar
  9. Heilmeyer, L.; “Die Behandlvng Eisenempfundlidher Anemien Mit Ascorbinsaurein Eisen Zugleieh Ein Betrag Zur Mechanisms der Eisnwirking und zur Frage der Eisenmnangel Krankheit,” Arch & KKKlin Med., 179–213, 231 (1936).Google Scholar
  10. Herr, quoted by Wiener; “Teleological Mechanisms Conference” Annal New York Academy of Science, Vol. 50, Art. 4, pp. 187–278, (Oct. 13, 1948).Google Scholar
  11. Larson, Svensk; “Kem Tidskrift” 51: (1939).Google Scholar
  12. Lipmann, Fritz; “Metabolic Process Patterns,” Currents in Biochemical Recearch, Interscience Publishers In. (1946).Google Scholar
  13. Livingston, “The Vicious Circle in Causalgia,” Annals New York Academy of Science, Vol. 50, (Oct. 13, 1948).Google Scholar
  14. Lovgren, Olle; “Studein Uber Den Intemediaren Stoffwechsel bei chronischer Polyarthritis,” Acta Medica, Scandinavica, Supp. CLXIII, Upsala (1945).Google Scholar
  15. Lovgren, Olle; Carlstrom, B.; and Sjogren, BB.; “Muskeladenylsaure und Adenylpyrophosphorsaure als Erganzung der Anemien wirking,” KKlin, Wochenshr, No. 31, Jahrg. 20, (2 Aug. 1941).Google Scholar
  16. McColl, L.; “Servomechanisms,” Van Nostrand (1945).Google Scholar
  17. Pickworth, FF. A.; and Watson, William P.; “Nasal and Oral Focal Sepsis in the Etiology of Gastro-Intestinal and Pulmonary Infective Diseases,” British Medical Journal, (1928 June 2).Google Scholar
  18. Pijoan; “The Antiscorbutic Properties of a Salt of Iron and Ascorbic Acid,” Science, 80–86, (1937).Google Scholar
  19. Rothmann, H.; Clinical Investigation on Adenin nucleotide in Blood and Gall. “Zeitschrift fui die Gesanite Experimentelle Medizin,” 77; 22, (1931).CrossRefGoogle Scholar
  20. Ruskin, Simon L.; “I. Studies on parallel action of vitamin C and calcium.” American Journal of Digestive Diseases, 5: 408, (1938); “II Studies in calcium metabolism: Further contribution to comparative studies of physicochemical properties of gluconate and cevitamate of calcium and of vitamin C” Ibid., 5: 676 (7939): III “Mechanisms of nephrosis in sinusitis in children.” Acta. Paediatric 16, 249, 274: 33. IV “Nucleic acid and nucleotide therapy in nasal diseases; Contribution to study of chemical aspects of nasal diseases.” Arch Otol., 22: 172, (Aug. 1935). V Influence of vitamin C on the antihistamine action of various drugs.” Arch. Otol, 36: 853–873 (Dec. 1942). VI “Adenylic acid in the treatment of agranulocytosis and mucous membrane lesions.” Am. J. Dig. Dis. VII “The therapeutic use of the amino acid. Histidine in allergy and shock. Histidine as a factor in histamine epinephrine balance.” Am. J. Dig. Dis. V. II., No. 7, (July 1943). VIII “High dosage vitamin C in allergy.” Am. J. Dig. dis. V. 12, No. 9, (Sept. 1945). IX “The role of the coenzymes of the B complex vitamins and amino acids in muscle metabolism and balanced nutrition.” Am. J. Dig. Dis. (April 1946).Google Scholar
  21. Ruskin, S. L. and Jonnard, R.; Etudes physical-chemic. Compare due gluconate, due sel de calcium et de la vitamine C. Compt. Rend de Biol., 28: 266–268, 38.Google Scholar
  22. Ruskin, S. L. and Katz, E.; Therapeutic action of nucleotides; Treatment of whole blood picture with ferrous adenylate. Ann. Int. Med., 9, 11, 36, 1549, 1560 (May 1936).Google Scholar
  23. Ruskin, Smion L.; “The Dynamics of Muscle Tonus and its relationship to Circulatory Failure.” Part III, A new approach to the treatment of hypertension and circulatory failure by use of the iron salt of the adenylic nucleotide, A. Jour. Dig Dis., Vol. 15, No. 8, (Aug. 1948).Google Scholar
  24. Rosenblueth, Wiener, and Biglow; “Behaviour Purpose and Teleology,” Philosphy of Science, Vol. 10, pp. 18–24 (1943).CrossRefGoogle Scholar
  25. Sluder, G.; “Headaches and Eye Disorders of Nasal Origin,” C. V. Mosby.Google Scholar
  26. Speransky, A. D.; “A Basis for the theory of Medicine,” International Publications.Google Scholar
  27. Weiner, Norbert; “Cylernetics, Control and Communication in the Animal and the Machine,” Wiley & Sons (1948).Google Scholar
  28. Weiner, N.; Rosenblueth, A.; Conduction of Impulses in Cardiac Muscle,” Arch Institute Cardiaol Mex, 16; 205; 265.Google Scholar
  29. Weiner, N.; “Time, Communication and the Nervous System,” Annals of N. Y. Academy of Science, VVol. 50, Art. 4, pp. 197, (Oct. 13, 1948).CrossRefGoogle Scholar
  30. *Ruskin, Simon L.; “The Control of Muscle Spasm and Arthritic Pain through Sympatheitc Block at the Nasal Ganglion and the Use of the Adenylic Nucleotide,” Contributions to the Physiology of Muscle Metabolism, Part II Amer. J. of Dig. Dis., 13, No. 10, (Oct. 1946).Google Scholar

Copyright information

© Springer 1949

Authors and Affiliations

  • Simon L. Ruskin
    • 1
  1. 1.New York

Personalised recommendations